Healthcare Holding B.V. Gilde Sells 99,812 Shares of Shoulder Innovations (NYSE:SI) Stock

Shoulder Innovations, Inc. (NYSE:SI) major shareholder Healthcare Holding B.V. Gilde sold 99,812 shares of the firm’s stock in a transaction that occurred on Tuesday, August 4th. The shares were sold at an average price of $22.77, for a total value of $2,272,719.24. Following the completion of the transaction, the insider directly owned 2,221,640 shares in the company, valued at $50,586,742.80. The trade was a 4.30% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Large shareholders that own 10% or more of a company’s stock are required to disclose their sales and purchases with the SEC.

Healthcare Holding B.V. Gilde also recently made the following trade(s):

• On Monday, August 3rd, Healthcare Holding B.V. Gilde sold 10,751 shares of Shoulder Innovations stock. The stock was sold at an average price of $22.71, for a total value of $244,155.21.
• On Friday, July 31st, Healthcare Holding B.V. Gilde sold 20,034 shares of Shoulder Innovations stock. The shares were sold at an average price of $22.73, for a total transaction of $455,372.82.
• On Thursday, July 30th, Healthcare Holding B.V. Gilde sold 28,245 shares of Shoulder Innovations stock. The stock was sold at an average price of $23.36, for a total transaction of $659,803.20.

Shoulder Innovations Stock Performance

Shares of NYSE SI traded down $0.13 during trading hours on Wednesday, hitting $22.56. 54,831 shares of the stock were exchanged, compared to its average volume of 92,520. Shoulder Innovations, Inc. has a one year low of $10.92 and a one year high of $24.59. The company’s 50 day moving average is $19.50 and its 200 day moving average is $15.92. The company has a debt-to-equity ratio of 0.11, a current ratio of 11.81 and a quick ratio of 10.04. The firm has a market capitalization of $467.89 million and a P/E ratio of -0.14.

Shoulder Innovations (NYSE:SI) last released its earnings results on Wednesday, May 13th. The company reported ($0.41) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.44) by $0.03. Shoulder Innovations had a negative net margin of 81.78% and a negative return on equity of 35.11%. The firm had revenue of $16.71 million during the quarter. On average, research analysts expect that Shoulder Innovations, Inc. will post -1.67 EPS for the current year.

Hedge Funds Weigh In On Shoulder Innovations

Several institutional investors and hedge funds have recently added to or reduced their stakes in SI. Sectoral Asset Management Inc. raised its holdings in Shoulder Innovations by 14.4% in the 4th quarter. Sectoral Asset Management Inc. now owns 492,435 shares of the company’s stock valued at $7,042,000 after acquiring an additional 62,153 shares in the last quarter. Deerfield Management Company L.P. bought a new stake in shares of Shoulder Innovations during the third quarter valued at approximately $6,056,000. Alyeska Investment Group L.P. acquired a new position in shares of Shoulder Innovations in the third quarter valued at $5,667,000. Roubaix Capital LLC lifted its position in Shoulder Innovations by 61.9% in the first quarter. Roubaix Capital LLC now owns 257,121 shares of the company’s stock worth $3,736,000 after purchasing an additional 98,305 shares during the period. Finally, Vanguard Group Inc. bought a new position in Shoulder Innovations in the third quarter worth $1,836,000.

Wall Street Analysts Forecast Growth

Several analysts recently weighed in on the company. Piper Sandler restated an “overweight” rating and set a $19.00 target price (up from $18.00) on shares of Shoulder Innovations in a research note on Friday, May 8th. Weiss Ratings raised Shoulder Innovations from a “sell (d-)” rating to a “sell (d)” rating in a research report on Monday. Finally, UBS Group began coverage on shares of Shoulder Innovations in a research report on Tuesday, July 28th. They set a “buy” rating and a $27.00 target price on the stock. Six investment analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, Shoulder Innovations presently has a consensus rating of “Moderate Buy” and a consensus price target of $22.00.

About Shoulder Innovations

Shoulder Innovations (NYSE:SI) is a medical device company focused on the design, development and commercialization of shoulder implant systems and related surgical instruments for orthopedic surgery. The company’s product portfolio includes modular shoulder prostheses, humeral and glenoid components, and instrumentation kits designed to facilitate both primary and revision shoulder arthroplasty procedures. Emphasizing a patient-centric approach, Shoulder Innovations works to offer implant solutions that aim to restore mobility and reduce post-operative complications.

In addition to its core implant offerings, Shoulder Innovations provides comprehensive clinical support and training programs for surgeons and operating room teams.